THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Equity / COM
Total 13F shares
122,266,742
Share change
+12,949,133
Total reported value
$716,480,520
Put/Call ratio
28%
Price per share
$5.86
Number of holders
113
Value change
+$70,338,173
Number of buys
65
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q3 2015

As of 30 Sep 2015, THERAPEUTICSMD INC - COM (TXMD) was held by 113 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 122,266,742 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Bank of New York Mellon Corp, PRICE T ROWE ASSOCIATES INC /MD/, FRANKLIN RESOURCES INC, GILDER GAGNON HOWE & CO LLC, JPMORGAN CHASE & CO, VANGUARD GROUP INC, BlackRock Fund Advisors, and STATE STREET CORP. This page lists 113 institutional shareholders reporting positions in this security for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.